These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21652264)

  • 1. MicroRNA pharmacogenomics: post-transcriptional regulation of drug response.
    Rukov JL; Shomron N
    Trends Mol Med; 2011 Aug; 17(8):412-23. PubMed ID: 21652264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics genes show varying perceptibility to microRNA regulation.
    Rukov JL; Vinther J; Shomron N
    Pharmacogenet Genomics; 2011 May; 21(5):251-62. PubMed ID: 21499217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and pharmacogenomics.
    Shomron N
    Pharmacogenomics; 2010 May; 11(5):629-32. PubMed ID: 20415550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and identification of reliable reference genes for pharmacogenomics, toxicogenomics, and small RNA expression analysis.
    Chen D; Pan X; Xiao P; Farwell MA; Zhang B
    J Cell Physiol; 2011 Oct; 226(10):2469-77. PubMed ID: 21412770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current knowledge of microRNA characterization in agricultural animals.
    Liu HC; Hicks JA; Trakooljul N; Zhao SH
    Anim Genet; 2010 Jun; 41(3):225-31. PubMed ID: 19968640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology.
    Chen K; Song F; Calin GA; Wei Q; Hao X; Zhang W
    Carcinogenesis; 2008 Jul; 29(7):1306-11. PubMed ID: 18477647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small but influential: the role of microRNAs on gene regulatory network and 3'UTR evolution.
    Zhang R; Su B
    J Genet Genomics; 2009 Jan; 36(1):1-6. PubMed ID: 19161940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
    Kaucsár T; Rácz Z; Hamar P
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors.
    Nakajima M; Yokoi T
    Pharmacol Ther; 2011 Sep; 131(3):330-7. PubMed ID: 21565218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microRNAs in the regulation of drug metabolizing and transporting genes and the response to environmental toxicants.
    Koturbash I; Beland FA; Pogribny IP
    Expert Opin Drug Metab Toxicol; 2012 May; 8(5):597-606. PubMed ID: 22435483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the biological effect of polymorphisms within microRNA binding sites.
    Landi D; Barale R; Gemignani F; Landi S
    Methods Mol Biol; 2011; 676():197-210. PubMed ID: 20931399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micro RNAs: tiny sequences with enormous potential.
    Shruti K; Shrey K; Vibha R
    Biochem Biophys Res Commun; 2011 Apr; 407(3):445-9. PubMed ID: 21419103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural selection on human microRNA binding sites inferred from SNP data.
    Chen K; Rajewsky N
    Nat Genet; 2006 Dec; 38(12):1452-6. PubMed ID: 17072316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
    Johnson AD; Wang D; Sadee W
    Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in miRNA expression in solid tumors: an miRNA profiling in melanomas.
    Molnár V; Tamási V; Bakos B; Wiener Z; Falus A
    Semin Cancer Biol; 2008 Apr; 18(2):111-22. PubMed ID: 18296065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential role of microRNAs in human diseases and the exploration on design of small molecule agents].
    Zhang Y; Lu YJ; Yang BF
    Yao Xue Xue Bao; 2007 Nov; 42(11):1115-21. PubMed ID: 18300464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics: role in medicines approval and clinical use.
    Novelli G; Borgiani P; Ciccacci C; Di Daniele N; Sirugo G; Papaluca Amati M
    Public Health Genomics; 2010; 13(5):284-91. PubMed ID: 19815999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy.
    Bao BY; Pao JB; Huang CN; Pu YS; Chang TY; Lan YH; Lu TL; Lee HZ; Juang SH; Chen LM; Hsieh CJ; Huang SP
    Clin Cancer Res; 2011 Feb; 17(4):928-36. PubMed ID: 21149617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological potential of RNAi--focus on miRNA.
    Pfeifer A; Lehmann H
    Pharmacol Ther; 2010 Jun; 126(3):217-27. PubMed ID: 20388525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.